Omeros reported $-46314000 in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acelrx Pharmaceuticals ACRX:US USD 27.54M 5.6M
Adma Biologics ADMA:US USD 100.38M 14.02M
Aerie Pharmaceuticals AERI:US USD -163982000 22.85M
Alnylam Pharmaceuticals ALNY:US USD -67638000 243.68M
Biomarin Pharmaceutical BMRN:US USD 4.57B 63.71M
Cytokinetics CYTK:US USD -15977000 127.39M
Gilead Sciences GILD:US USD 21.06B 821M
Heron Therapeutics HRTX:US USD 22.45M 44.19M
Insmed INSM:US USD -29959000 74.2M
Intercept Pharmaceuticals ICPT:US USD 107.68M 477.51M
Knight Therapeutics Inc GUD:CN CAD 854.52M 24.83M
Macrogenics MGNX:US USD 122.96M 19.52M
Mirati Therapeutics MRTX:US USD 1.13B 17.05M
Omeros OMER:US USD -46314000 13.61M
Pacira Pharmaceuticals PCRX:US USD 770.12M 13.49M
Regulus Therapeutics RGLS:US USD 39.67M 2.7M
Sangamo Biosciences SGMO:US USD 309.15M 9.13M
Sarepta Therapeutics SRPT:US USD 430.84M 295.62M
United Therapeutics UTHR:US USD 4.56B 243.8M
Vertex Pharmaceuticals VRTX:US USD 13.03B 1.1B
Vital Therapies VTL:US USD 108.81M 19.04M
Xoma XOMA:US USD 130.32M 4.63M